02.17.16
BASi
1Q Revenues: $4.9 million (-16%)
1Q Loss: $506,000 (earnings were $182,000 1Q15)
Comments: Service revenue for the quarter decreased 8% to $4.1 million. Increased preclinical services revenue was more than offset by lower other lab services revenue, due to fewer bioequivalence studies, and a decline in Bioanalytical revenue.Products sales were down 42% in the quarter to $840,000, due to lower sales of Culex automated in-vivo sampling systems and analytical instruments.
1Q Revenues: $4.9 million (-16%)
1Q Loss: $506,000 (earnings were $182,000 1Q15)
Comments: Service revenue for the quarter decreased 8% to $4.1 million. Increased preclinical services revenue was more than offset by lower other lab services revenue, due to fewer bioequivalence studies, and a decline in Bioanalytical revenue.Products sales were down 42% in the quarter to $840,000, due to lower sales of Culex automated in-vivo sampling systems and analytical instruments.
